In the last decade, the melanoma treatment landscape has changed dramatically following the introduction of effective systemic treatments, including immune checkpoint inhibitors and BRAF/MEK inhibitors, and the increased use of stereotactic radiotherapy (SRT).6, 7, 8, 9, 10, 11, 12, 13, 14. The gene discussed is BRAF; the disease is melanoma.